G7 leaders' call on the fight against cancer
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC
Jérôme Salomon and Lutz Dommel: Cancer Becomes a Global Strategic Priority in Historic G7 Declaration
Delta Goodrem Inspiring Cancer Journey: Hodgkin Lymphoma, Recovery, and Eurovision Return
Yelena Janjigian Receives 2026 Fellowship Service Award at MSK
Neeraj Agarwal: AHA and ASCO Joint Statement on Defining Cardiovascular Endpoints in Oncology Trials
EMBER-3 PRO Analysis Supports Quality-of-Life Profile of Imlunestrant in Advanced ER-Positive/HER2-Negative Breast Cancer
LAGOON Trial: 3 Critical Results From Zepzelca in Second-Line SCLC
The ESMO Preceptorship on Small Cell Lung Cancer (SCLC) 2026 is an advanced educational medical program taking place in Lisbon, Portugal, from June 24–25, 2026. Co-chaired by Dr. Kersti Oselin and Dr. Giannis Mountzios, this intensive course focuses on translating the fundamental biology of SCLC into clinical practice. The academic curriculum provides a comprehensive overview […]
